“Comparative Regression Discontinuity and Regression Discontinuity as Alternatives to Randomized Controlled Trials for Estimating Average Treatment Effects: Evidence from the Benefit Offset National Demonstration,” by Duncan Chaplin, Charles Tilley, Denise Hoffman and John T. Jones (WP No. 2022-7, August 2022, .pdf format, 59p.). Note: A link to the abstract and the full-text of this paper is available at: